A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas

NCT01765088 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Anaplastic Oligoastrocytoma
Anaplastic Astrocytoma
Glioblastoma

Interventions

DRUG: Temozolomide
DRUG: α-IFN

Sponsor

Sun Yat-sen University